Burn Blend

$200.00

Burn Blend is a combination of Retatrutide and Tirzepatide, designed to leverage the triple-agonist activity of investigational Retatrutide (GLP-1, GIP, and glucagon) alongside the dual-agonist activity of FDA-approved Tirzepatide (GLP-1 and GIP). This research-focused blend is studied for its potential to enhance metabolic effects, including appetite regulation, blood sugar control, and fat metabolism, by targeting multiple hormone pathways simultaneously. While preclinical and early clinical research suggests these combined actions may support weight regulation beyond either compound alone, such blends are considered experimental research compounds and are not approved therapies or standardized treatments.

SKU: VP-BURN Category:

Frequently Bought Together

Burn Blend - 20mg/20mg+Bacteriostatic Water - 30mL+Insulin Syringes - 100 CT
Price for all:   $330.00

PRODUCT FAQ

What is Burn Blend?
Burn Blend is a research peptide combination of Retatrutide (triple-agonist: GLP-1, GIP, glucagon) and Tirzepatide (dual-agonist: GLP-1, GIP), studied for its potential effects on metabolism, appetite, and fat regulation.

How does Burn Blend work in research models?
This combination targets multiple hormone pathways, including GLP-1, GIP, and glucagon signaling, to investigate potential effects on satiety, blood glucose regulation, energy balance, and fat metabolism.

Why combine Retatrutide and Tirzepatide?
Combining these peptides allows researchers to study potential **synergistic effects** on metabolic pathways that may exceed the activity of either peptide alone, particularly in appetite and weight regulation models.

What research areas use Burn Blend?
Burn Blend is used in laboratory research focusing on metabolic regulation, obesity models, blood glucose control, hormone signaling, and combination therapy mechanisms.

How do researchers measure the effects of Burn Blend?
Researchers typically monitor outcomes such as appetite signaling, hormonal responses (GLP-1, GIP, glucagon), metabolic rate, glucose handling, and fat metabolism in preclinical and laboratory studies to evaluate Burn Blend’s activity.